Fundraising Fox

Charles Oh

Chief Medical Officer at Centrexion Therapeutics

New York City Metropolitan Area

Find your path to Charles

424 people in our graph share verified history with Charles — schools, employers, funds. One of them is your warm intro.

Mathew KayeunlockedCharles: together at UNC Kenan-Flagler Business School
×8Charles: together at UNC Kenan-Flagler Business School
Charles: together at Washington University School of Medicine in St. Louis
×2Charles: together at University of Miami

Chief Medical Officer at Centrexion Therapeutics

Intro paths

→

In turn, Charles can intro founders to Centrexion Therapeutics's investors below.

Centrexion Therapeutics's investors · 6

6 Dimensions CapitalGrand CaymanCatalio Capital Management, LPNew YorkEFung CapitalShenzhenExome Asset ManagementNew York · since 2020New Enterprise Associates (NEA)Menlo Park · $200K – $40M checksQuan CapitalShanghai

Co-founders at Centrexion Therapeutics

JNJames N. Campbell
James N. CampbellPresident, Chief Scientific Officer

Experience

  1. Annexon BiosciencesSVP, Clinical Development - Neurosciencecurrent2026 — presentBrisbane, CA
  2. Centrexion Therapeutics Corp.Chief Medical Officer2026Boston, MA
  3. Centrexion Therapeutics Corp.Senior Vice President Clinical2025Boston, Massachusetts, United States
  4. CoriumChief Medical Officer2020 — 2025Boston, Massachusetts, United States
  5. Tremeau Pharmaceuticals, Inc.Member, Board of Directors2023 — 2024Concord, Massachusetts, United States
  6. Acorda Therapeutics, Inc.Senior Vice President Clinical Development2019 — 2020New York City Metropolitan Area
  7. Acorda Therapeutics, Inc.Vice President Clinical Development2016 — 2019New York City Metropolitan Area
  8. Purdue PharmaSenior Medical Director2012 — 2016Stamford, CT
  9. The Janssen Pharmaceutical Companies of Johnson & JohnsonSenior Director, Medical Affairs2011 — 2012Raritan, NJ
  10. Cordis, a Johnson & Johnson CompanyDirector, Clinical Development2009 — 2011Bridgewater, NJ
  11. Johnson & Johnson Pharmaceutical Research & Development LLCDirector, Clinical Development2005 — 2009Titusville, NJ
  12. Kaiser Permanente - Mid-Atlantic Permanente Medical Group (MAPMG)Attending Physician2004 — 2005Silver Springs, MD
  13. University of FloridaCardiology Fellowship2003 — 2004Jacksonville, Florida Area
  14. Hawaii Permanente Medical GroupAttending Physician2002 — 2003Honolulu, HI
  15. Thomas Jefferson UniversityInternal Medicine Resident1999 — 2002Greater Philadelphia Area
  16. University of Medicine and Dentistry of New JerseyClinical Pharmacology Research Fellowship1998 — 1999New Brunswick, NJ

Skills & more

Board of DirectorsStandard Operating Procedure (SOP)ImmunologyTeam ManagementSmall MoleculesAntibodiesInternal MedicinePharmacovigilanceBiopharmaceuticalsCNS disordersNeurologyClinical Development23
+8 moreDrug DevelopmentPharmaceutical IndustryClinical TrialsFDAClinical ResearchPain ManagementCardiologyMedical Devices

From Charles's professional profile.

Frequently asked questions

Who is Charles Oh?
Chief Medical Officer at Centrexion Therapeutics
Where does Charles Oh work?
Charles Oh is Chief Medical Officer at Centrexion Therapeutics.
Where did Charles Oh go to school?
Charles Oh studied at UNC Kenan-Flagler Business School (Master of Business Administration (MBA)); Washington University School of Medicine in St. Louis (Doctor of Medicine (MD)); University of Miami (Bachelor of Science (BS), Biology, General).

Same school

Also attended UNC Kenan-Flagler Business School222

Mathew KayeAccounting Manager at RevolutionFrancesco MoroPrincipal at Burda Principal InvestmentsAmol BhatHead of Investor Relations at Mucker CapitalJoe SantaBarbaraChief Financial Officer at .406 VenturesTony WellsVenture Partner at Copper Sky CapitalTroy ArnoldPartner, Echo Health Advisors at Echo Health Ventures

+ 216 more

Also attended Washington University School of Medicine in St. Louis27

Reid HuberPartner at Third Rock VenturesDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresBen ScruggsPartner at Hatteras Venture PartnersDaguang WangManaging Director at Yonjin Venture LLCDave VreelandSenior Managing Partner at Caduceus Capital Partners

+ 21 more

Also attended University of Miami153

Olivier GrindaVenture Partner at FJ LabsDr. John L Evans JrVenture Partner at Parkway Venture CapitalJaime NovoaInvestor at KfundDavid GoldbergBoard Partner at Alpaca VCAjoy MallikVenture Partner at Follow[the]SeedAlex GheorgheInvestor at Illuminate Financial

+ 147 more

Shared employers

Also worked at Annexon Biosciences6

LaToya CoffeyRegulatory Advisor at 2Flo VenturesDouglas LoveFounder at AnnexonEmmett CunninghamExecutive Officer, Director at EyconisWilliam WaddillExecutive Officer at Calithera BiosciencesGary YeungGeneral Partner at YK BioventuresEduardo DunayevichChief Medical Officer at Neurona Therapeutics

Also worked at Centrexion Therapeutics Corp.3

Jeffrey B. KindlerChief Executive Officer at Centrexion TherapeuticsKerrie L. BradyExecutive Officer at Centrexion TherapeuticsMike WardChief Financial Officer/Chief Operations Officer at Centrexion Therapeutics

Also worked at Tremeau Pharmaceuticals, Inc.1

Christoph BrojaPartner at EQT Life Sciences

Also worked at Acorda Therapeutics, Inc.8

Rachel Tsunemoto Hislop, PhDPrincipal, Director of Research at Two Bear CapitalMark RosenblumExecutive Vice President, Chief Financial Officer at Salarius PharmaceuticalsMichelle HuieFounder at ShopDotHank SaffersteinChief Executive Officer at Generian PharmaceuticalsMary FisherExecutive Officer, Director at ColorescienceMARTIN FREEDExecutive Officer at Civitas Therapeutics

+ 2 more